US Stock MarketDetailed Quotes

PSTX Poseida Therapeutics

Watchlist
  • 2.750
  • -0.170-5.82%
Trading Jun 6 11:57 ET
266.63MMarket Cap-2350P/E (TTM)

Poseida Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
172.09%28.14M
-50.42%64.7M
148.68%25M
-91.96%9.35M
641.22%20.01M
620.77%10.34M
317.73%130.49M
-67.82%10.05M
116.31M
2.7M
Operating revenue
172.09%28.14M
-50.42%64.7M
148.68%25M
-91.96%9.35M
641.22%20.01M
620.77%10.34M
317.73%130.49M
-67.82%10.05M
--116.31M
--2.7M
Cost of revenue
Gross profit
Operating expense
5.74%52.72M
1.98%194.21M
17.64%50.9M
2.35%45.57M
8.19%47.87M
-14.62%49.86M
10.30%190.44M
-11.17%43.27M
7.06%44.53M
-1.41%44.25M
Selling and administrative expenses
-17.02%9.8M
-0.28%37.44M
-5.43%8.86M
-13.81%8.09M
-6.07%8.68M
23.69%11.81M
4.52%37.54M
-2.51%9.37M
3.56%9.39M
4.13%9.24M
-General and administrative expense
-17.02%9.8M
-0.28%37.44M
-5.43%8.86M
-13.81%8.09M
-6.07%8.68M
23.69%11.81M
4.52%37.54M
-2.51%9.37M
3.56%9.39M
4.13%9.24M
Research and development costs
12.80%42.92M
2.53%156.77M
24.01%42.05M
6.67%37.48M
11.95%39.19M
-22.10%38.05M
11.82%152.9M
-13.30%33.9M
8.03%35.14M
-2.78%35.01M
Operating profit
37.80%-24.58M
-116.03%-129.5M
22.01%-25.91M
-150.46%-36.22M
32.95%-27.86M
30.63%-39.52M
57.61%-59.95M
-90.07%-33.22M
272.59%71.78M
7.43%-41.55M
Net non-operating interest income expense
-11.09%-2.25M
-36.12%-8.67M
-14.78%-2.27M
-25.97%-2.24M
-38.76%-2.14M
-88.30%-2.03M
-89.70%-6.37M
-135.12%-1.98M
-112.07%-1.78M
-83.04%-1.54M
Non-operating interest expense
11.09%2.25M
36.12%8.67M
14.78%2.27M
25.97%2.24M
38.76%2.14M
88.30%2.03M
89.70%6.37M
135.12%1.98M
112.07%1.78M
83.04%1.54M
Other net income (expense)
-5.23%2.56M
419.66%14.85M
30.28%2.83M
934.60%6.79M
4,784.62%2.54M
14,294.74%2.7M
-85.56%2.86M
-89.03%2.17M
21,766.67%656K
205.88%52K
Other non- operating income (expenses)
-5.23%2.56M
419.66%14.85M
30.28%2.83M
934.60%6.79M
4,784.62%2.54M
14,294.74%2.7M
-85.56%2.86M
-89.03%2.17M
21,766.67%656K
205.88%52K
Income before tax
37.51%-24.27M
-94.34%-123.32M
23.25%-25.35M
-144.82%-31.67M
36.20%-27.46M
33.09%-38.85M
49.22%-63.46M
-2,348.20%-33.03M
266.56%70.66M
5.84%-43.04M
Income tax
-80.33%107K
0
-57.54%107K
544K
292K
252K
Net income
37.51%-24.27M
-92.85%-123.43M
23.92%-25.35M
-145.13%-31.78M
36.20%-27.46M
33.09%-38.85M
48.79%-64M
-2,368.07%-33.32M
265.97%70.41M
5.84%-43.04M
Net income continuous Operations
37.51%-24.27M
-92.85%-123.43M
23.92%-25.35M
-145.13%-31.78M
36.20%-27.46M
33.09%-38.85M
48.79%-64M
-2,368.07%-33.32M
265.97%70.41M
5.84%-43.04M
Minority interest income
Net income attributable to the parent company
37.51%-24.27M
-92.85%-123.43M
23.92%-25.35M
-145.13%-31.78M
36.20%-27.46M
33.09%-38.85M
48.79%-64M
-2,368.07%-33.32M
265.97%70.41M
5.84%-43.04M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
37.51%-24.27M
-92.85%-123.43M
23.92%-25.35M
-145.13%-31.78M
36.20%-27.46M
33.09%-38.85M
48.79%-64M
-2,368.07%-33.32M
265.97%70.41M
5.84%-43.04M
Basic earnings per share
44.44%-0.25
-53.93%-1.37
33.33%-0.26
-138.04%-0.35
53.62%-0.32
51.61%-0.45
55.72%-0.89
-2,050.00%-0.39
235.29%0.92
6.76%-0.69
Diluted earnings per share
44.44%-0.25
-53.93%-1.37
33.33%-0.26
-138.04%-0.35
53.62%-0.32
51.61%-0.45
55.72%-0.89
-2,050.00%-0.39
235.29%0.92
6.76%-0.69
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 172.09%28.14M-50.42%64.7M148.68%25M-91.96%9.35M641.22%20.01M620.77%10.34M317.73%130.49M-67.82%10.05M116.31M2.7M
Operating revenue 172.09%28.14M-50.42%64.7M148.68%25M-91.96%9.35M641.22%20.01M620.77%10.34M317.73%130.49M-67.82%10.05M--116.31M--2.7M
Cost of revenue
Gross profit
Operating expense 5.74%52.72M1.98%194.21M17.64%50.9M2.35%45.57M8.19%47.87M-14.62%49.86M10.30%190.44M-11.17%43.27M7.06%44.53M-1.41%44.25M
Selling and administrative expenses -17.02%9.8M-0.28%37.44M-5.43%8.86M-13.81%8.09M-6.07%8.68M23.69%11.81M4.52%37.54M-2.51%9.37M3.56%9.39M4.13%9.24M
-General and administrative expense -17.02%9.8M-0.28%37.44M-5.43%8.86M-13.81%8.09M-6.07%8.68M23.69%11.81M4.52%37.54M-2.51%9.37M3.56%9.39M4.13%9.24M
Research and development costs 12.80%42.92M2.53%156.77M24.01%42.05M6.67%37.48M11.95%39.19M-22.10%38.05M11.82%152.9M-13.30%33.9M8.03%35.14M-2.78%35.01M
Operating profit 37.80%-24.58M-116.03%-129.5M22.01%-25.91M-150.46%-36.22M32.95%-27.86M30.63%-39.52M57.61%-59.95M-90.07%-33.22M272.59%71.78M7.43%-41.55M
Net non-operating interest income expense -11.09%-2.25M-36.12%-8.67M-14.78%-2.27M-25.97%-2.24M-38.76%-2.14M-88.30%-2.03M-89.70%-6.37M-135.12%-1.98M-112.07%-1.78M-83.04%-1.54M
Non-operating interest expense 11.09%2.25M36.12%8.67M14.78%2.27M25.97%2.24M38.76%2.14M88.30%2.03M89.70%6.37M135.12%1.98M112.07%1.78M83.04%1.54M
Other net income (expense) -5.23%2.56M419.66%14.85M30.28%2.83M934.60%6.79M4,784.62%2.54M14,294.74%2.7M-85.56%2.86M-89.03%2.17M21,766.67%656K205.88%52K
Other non- operating income (expenses) -5.23%2.56M419.66%14.85M30.28%2.83M934.60%6.79M4,784.62%2.54M14,294.74%2.7M-85.56%2.86M-89.03%2.17M21,766.67%656K205.88%52K
Income before tax 37.51%-24.27M-94.34%-123.32M23.25%-25.35M-144.82%-31.67M36.20%-27.46M33.09%-38.85M49.22%-63.46M-2,348.20%-33.03M266.56%70.66M5.84%-43.04M
Income tax -80.33%107K0-57.54%107K544K292K252K
Net income 37.51%-24.27M-92.85%-123.43M23.92%-25.35M-145.13%-31.78M36.20%-27.46M33.09%-38.85M48.79%-64M-2,368.07%-33.32M265.97%70.41M5.84%-43.04M
Net income continuous Operations 37.51%-24.27M-92.85%-123.43M23.92%-25.35M-145.13%-31.78M36.20%-27.46M33.09%-38.85M48.79%-64M-2,368.07%-33.32M265.97%70.41M5.84%-43.04M
Minority interest income
Net income attributable to the parent company 37.51%-24.27M-92.85%-123.43M23.92%-25.35M-145.13%-31.78M36.20%-27.46M33.09%-38.85M48.79%-64M-2,368.07%-33.32M265.97%70.41M5.84%-43.04M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 37.51%-24.27M-92.85%-123.43M23.92%-25.35M-145.13%-31.78M36.20%-27.46M33.09%-38.85M48.79%-64M-2,368.07%-33.32M265.97%70.41M5.84%-43.04M
Basic earnings per share 44.44%-0.25-53.93%-1.3733.33%-0.26-138.04%-0.3553.62%-0.3251.61%-0.4555.72%-0.89-2,050.00%-0.39235.29%0.926.76%-0.69
Diluted earnings per share 44.44%-0.25-53.93%-1.3733.33%-0.26-138.04%-0.3553.62%-0.3251.61%-0.4555.72%-0.89-2,050.00%-0.39235.29%0.926.76%-0.69
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday+0.17%